Literature DB >> 20051814

Immunohistochemical study of the expression of matrix metalloproteinase-9 in skin lesions of mycosis fungoides.

Hoda Rasheed1, Marwa Mohsen Tolba Fawzi, Mona R E Abdel-Halim, Amal M Eissa, Nahla Mohammed Salem, Soheir Mahfouz.   

Abstract

Matrix metalloproteinase-9 (MMP-9) has been correlated with poor clinical outcome in various malignancies and is associated with enhanced tumor growth and dissemination through its role in angiogenesis. This study was carried out to review the immunohistological staining of MMP-9 in skin lesions of different stages of mycosis fungoides (MF). The study was carried on 22 patients with MF and 10 healthy controls. Immunohistochemical staining using MMP-9 monoclonal anti-human antibodies was performed to determine the intensity of expression and distribution pattern of MMP-9 in MF lesions and in normal control skin. The general intensity of expression of MMP-9 was found to be significantly higher in cases with MF than in controls, and it increased in direct proportion to the increase in disease severity, being greatest in the tumor stages. A significantly greater number of blood vessels were found in cases with MF when compared with controls, and the MMP-9 expression by endothelial cells was significantly higher in endothelial cells within tumor cell aggregates than in endothelial cells outside the tumor cell aggregates. This study raises the possibility that MMP-9 may play an important role in the development of MF lesions, and its significantly higher expression in tumor stages may point to a possible role in disease progression. Further studies are needed to validate these findings and to assess the possible therapeutic role of drugs targeting MMP-9 in the treatment of MF.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20051814     DOI: 10.1097/DAD.0b013e3181b72678

Source DB:  PubMed          Journal:  Am J Dermatopathol        ISSN: 0193-1091            Impact factor:   1.533


  4 in total

1.  Successful Treatment of MMP-9-Expressing Angiosarcoma with Low-Dose Docetaxel and Bisphosphonate.

Authors:  Masaya Ishibashi; Taku Fujimura; Akira Hashimoto; Takahiro Haga; Kaoru Onami; Akira Tsukada; Yumi Kambayashi; Takanori Hidaka; Sadanori Furudate; Ryoko Shimada; Setsuya Aiba
Journal:  Case Rep Dermatol       Date:  2012-01-11

2.  PD-L1-Expressing Radiation-Associated Angiosarcoma after Primary Breast Cancer.

Authors:  Kana Takeda; Taku Fujimura; Chunbing Lyu; Akira Tsukada; Kenichiro Tsuchiyama; Akira Hashimoto; Setsuya Aiba
Journal:  Case Rep Oncol       Date:  2018-05-29

3.  Potential use of bisphosphonates in invasive extramammary Paget's disease: an immunohistochemical Investigation.

Authors:  Taku Fujimura; Sadanori Furudate; Yumi Kambayashi; Setsuya Aiba
Journal:  Clin Dev Immunol       Date:  2013-03-31

Review 4.  The Role of Tumor Microenvironment in the Pathogenesis of Sézary Syndrome.

Authors:  Denis Miyashiro; Bruno de Castro E Souza; Marina Passos Torrealba; Kelly Cristina Gomes Manfrere; Maria Notomi Sato; José Antonio Sanches
Journal:  Int J Mol Sci       Date:  2022-01-15       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.